• Nachrichtendetail
• 

23.04.2024 06:53:43 - dpa-AFX: *VERTEX PHARMA OBTAINS EXCLUSIVE LICENSE TO TREEFROG'S PROPRIETARY CELL MANUFACTURING TECHNOLOGY, C-STEM

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	VERTEX PHARMAC. DL-,01	882807	Xetra	404,500	30.05.24 17:21:32	-5,600	-1,37%	404,550	406,150	407,350	410,100